Description
Monoclonal antibody, an epochal drug variety, plays an important role in the upgrading process of treatments for tumor and autoimmune disease, and has become a mainstream in the global market of targeting therapeutic agents. The manufacturers of antibody mainly concentrate in the hands of such drug giants as Roche, Amgen, Johnson & Johnson, Abbott, Novartis and Merck, among which Roche’s Genetech boasts of the largest amount of monoclonal antibody varieties.
View Full Report at: http://www.marketresearchreports.biz/analysis/294314
Developed by Genentech, trastuzumab was approved by FDA to be used in clinic in Sep. 1998 under the trade name of Herceptin, a major product of Roche. In 2013, the sales value of trastuzumab was USD 6.56 billion around the world.
After entering China in 2002 for the treatment of HER2 metastatic breast cancer, trastuzumab develops fast with annual sales value rising from less than CNY 20 million in 2005 to CNY 577 million in 2014 and CAGR during this period reaching up to 52.9%. Currently, trastuzumab in the Chinese market are monopolized by the subsidiary companies of Roche such as Genentech and Shanghai Roche Pharmaceutical Co., Ltd who has the largest market share of 80.60% with sales value in 2014 reaching up to CNY 465 million.
Due to its low toxicity and obvious therapeutic effects, trastuzumab can prolong patients’ lives and improve the life quality of patients with advanced cancer, thus becoming the major driving force behind the growth of tumor monoclonal antibody market. The market size of trastuzumab in China is expected to keep expanding in the next few years.
Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/294314
Readers can get at least the following information from this report:
market size of trastuzumab in China
price of trastuzumab in Chinese market
major manufacturers of trastuzumab in Chinese market
market outlook of trastuzumab in China
The author suggests the following groups of people purchase this report:
manufacturers of monoclonal antibody
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Content
1 Related Concepts of Trastuzumab
1.1 Indication
1.2 Sales Status in Global Market
2 Market Profile of Trastuzumab in China
2.1 Patent and Approval Status of Trastuzumab in China
2.2 Major Manufacturers
2.3 Market Size
3 Survey on Sales Status of Trastuzumab in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz
Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E:
[email protected]